Drug Shortage Report for MYLAN-ELETRIPTAN

Last updated on 2021-02-04 History
Report ID 128484
Drug Identification Number 02342243
Brand name GD-ELETRIPTAN
Common or Proper name Eletriptan
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ELETRIPTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size BLST 1x6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-11-17
Estimated end date
Actual end date 2021-02-03
Shortage status Resolved
Updated date 2021-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-11-17 English Compare
v2 2020-11-17 French Compare
v3 2020-11-18 English Compare
v4 2021-02-03 English Compare
v5 2021-02-03 French Compare
v6 2021-02-04 English Compare

Showing 1 to 6 of 6